Diane George

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Diane George sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials none currently recruiting early-phase tilt upper half by trial count

Diane George: 2 sponsored US clinical trials, none currently recruiting.

Diane George sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Familial Hemophagocytic Lymphocytosis, with 1 trials.

Mid-pack sponsor footprint

Diane George is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Indexed trials (enrollment closed)

2 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 1

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

NCT02061800
ACTIVE NOT RECRUITING Phase 1

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

NCT01966367

Phase Distribution

PhaseTrial count
Phase 1 2

Therapeutic Areas

Familial Hemophagocytic Lymphocytosis 1
Histiocytic Syndrome 1
Acquired Immunodeficiency Syndromes 1
Primary Immunodeficiency Syndromes 1
Schwachman Diamond Syndrome 1
Lymphoma (Hodgkin's and Non-Hodgkin's) 1
Juvenile Myelomonocytic Leukemia (JMML) 1
Amegakaryocytic Thrombocytopenia 1
Severe Congenital Neutropenia 1
Chronic Myeloid Leukemia (CML) 1

How the Diane George early-phase archive is shaped

2 indexed studies, none listed as recruiting (0% open).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Familial Hemophagocytic Lymphocytosis (1 trial), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Diane George: archived-pipeline peers nationwide

Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Diane George sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Diane George1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Diane George sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Diane George sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Diane George page

2 registered trials is a research-attention snapshot, not an endorsement of Diane George or any single study.

  • None of Diane George's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Familial Hemophagocytic Lymphocytosis is the condition Diane George studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Familial Hemophagocytic Lymphocytosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Diane George pipeline card: 2 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.